Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Grimes, Amanda
PINES, NCT03939637: Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children	Active, not recruiting	3	122	US	Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin	Baylor College of Medicine, Boston Children's Hospital, University of California, San Francisco	Immune Thrombocytopenia	03/25	12/25
Lilla, Stephanie F
PINES, NCT03939637: Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children	Active, not recruiting	3	122	US	Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin	Baylor College of Medicine, Boston Children's Hospital, University of California, San Francisco	Immune Thrombocytopenia	03/25	12/25